Daily non-political popular news in brief.

Bad News, Good News: ADHD-risk gene has silver lining

08-11-2007 · Science News Online

A gene variant that increases the risk for attention deficit-hyperactivity disorder in young children also helps the problem resolve by the teen years.

Keywords: bad, news, good, adhd-risk, gene, silver, lining, new, adhd, risk

« Previous | Next »

Similar news on "Bad News, Good News: ADHD-risk gene has silver lining":

Weight-loss supplement shows good and bad traits
01-30-2007 · EurekAlert!
A supplement some people turn to in hopes of losing a few pounds may have some previously unknown, unsavory side effects, suggest two new studies. Researchers studied how mice and rats responded to the supplement conjugated linoleic acid (CLA), an essential amino acid found in trace amounts primarily in beef, lamb and milk. Synthetic forms of CLA are marketed as supplements that help reduce body fat, and some manufacturers also tout CLA for reducing the risk of diabetes and certain types of cancer.
Similar news · Read more »
Gene predicts better outcome as cortex normalizes in teens with ADHD
08-06-2007 · EurekAlert!
Brain areas that control attention were thinnest in children with attention deficit hyperactivity disorder who carried a particular version of a gene. However, the areas, on the right side of the brain's cortex, normalized during the teen years, coinciding with clinical improvement. While the gene variant increased risk for ADHD, it also predicted better clinical outcomes and higher IQ than two other common versions of the same gene in youth with ADHD.
Similar news · Read more »
Performance of wide receivers, running backs post-ACL injury falls by one third
11-30-2006 · EurekAlert!
The good news for NFL players who sustain an injury to their anterior cruciate ligament (ACL) is that they'll likely play again in the NFL. The bad news is, they'll return with diminished performance on the field, concludes a study in the December issue of The American Journal of Sports Medicine.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »
Dominant cholesterol-metabolism ideas challenged by new research
08-15-2007 · EurekAlert!
A team of researchers investigating cholesterol and lipid transport has performed experiments that cast serious doubt on the dominant hypothesis of how the body rids its cells of "bad" cholesterol and increases "good" cholesterol. Cholesterol metabolism is an area of intense inquiry because high levels of LDL cholesterol or total cholesterol put about half of all Americans at significant risk of heart disease.
Similar news · Read more »
South Asian Scots have increased risk of heart attacks
07-05-2007 · EurekAlert!
Scots of South Asian descent are significantly more likely to suffer a heart attack than the rest of the Scottish population, according to a report published in the online open access journal BMC Public Health. The good news is that they are also more likely to survive this traumatic event than their non-Asian countrymen.
Similar news · Read more »
2 heads are better than 1: 2 dysfunctional DNA repair pathways kill tumor cells
04-12-2007 · EurekAlert!
Individuals who inherit one mutant copy of any one of about 12 genes that make the proteins of the Fanconi Anemia pathway are at increased risk of developing cancer. This occurs when the remaining "good" copy of the gene becomes mutated in a specific cell type. However, hope of a new treatment for these cancers has now been provided by a new study indicating that inhibiting the protein ATM can kill these cancer cells.
Similar news · Read more »
U. of Colorado study finds growing up in bad neighborhood not as harmful as expected
12-13-2006 · EurekAlert!
There's good news for children growing up in bad neighborhoods in a comprehensive, 8-year study led by University of Colorado at Boulder. The successful development of children in Denver and Chicago from the best neighborhoods was 63 percent, while the success rate for children living in high-poverty, disadvantaged neighborhoods was still relatively high, at 52 percent.
Similar news · Read more »
Cancer cells more likely to genetically mutate
02-18-2007 · EurekAlert!
When cells become cancerous, they also become 100 times more likely to genetically mutate than regular cells, researchers have found. The findings may explain why cells in a tumor have so many genetic mutations, but could also be bad news for cancer treatments that target a particular gene controlling cancer malignancy.
Similar news · Read more »
JCI table of contents: Aug. 23, 2007
08-23-2007 · EurekAlert!
This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, Aug. 23, 2007, in the JCI, including: New weapon to fight leukemia; Inhaling helps heal liver transplant recipients; Being fat needn't be all bad news; DNA provides clues to outcome in patients with liver cancer; Risk factor for heart disease: Just say NO; Building muscle requires Foxo1; and others.
Similar news · Read more »